Treatment Strategy for Infantile Hemangiomas: From the Perspective of A Clinical Dermatologist
نویسندگان
چکیده
منابع مشابه
Novel treatment for infantile hemangiomas.
Evidence Oral propranolol • In an RCT (40 children, aged 9 weeks to 5 years, followed for 6 months),1 2 mg/kg of propranolol (divided 3 times daily) stopped IH growth by week 4 for all children and reduced IH volume at all weeks compared with placebo (eg, -48.5% vs 17.9% in week 12, P = .03). No significant hypotension, hypoglycemia, or bradycardia were reported. • In a systematic review of 40 ...
متن کاملPropranolol for treatment of infantile hemangiomas*
Infantile hemangioma is the most common vascular tumor in early childhood. Propranolol has been successfully used recently in a limited number of children with Infantile hemangioma. We present 6 cases of Infantile hemangioma, at a single dermatological center, which responded to oral propranolol with good results.
متن کاملA β - antagonist for the treatment of infantile hemangiomas
Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA Department of Pediatrics, University of Texas Health Science Center, Houston, TX, USA *Author for correspondence: [email protected] “Due to very high efficacy rates and fewer side effects than systemic corticosteroid therapy, β-blockers have become accepted as the first line in treatment of infant...
متن کاملDistribution, clinical characteristics, and surgical treatment of lip infantile hemangiomas.
IMPORTANCE Infantile hemangiomas (IHs) are the most common tumors of infancy. OBJECTIVES To describe the patterns of occurrence of lip IHs and correlate these findings with patterns of anatomical distortion and predictable clinical outcomes and to describe the surgical management of these lesions. DESIGN A retrospective medical record review of patients diagnosed as having facial IH of the ...
متن کاملTopical Timolol Maleate Treatment of Infantile Hemangiomas.
BACKGROUND There has been a dramatic increase in the off-label use of ophthalmic timolol maleate, a β-blocker used for infantile hemangioma (IH) treatment as a topical counterpart to oral propranolol. Its safety and efficacy in a pediatric population with IH have not been evaluated in a large cohort. Our goal was to retrospectively assess timolol's effectiveness, discern characteristics associa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nippon Laser Igakkaishi
سال: 2021
ISSN: 0288-6200,1881-1639
DOI: 10.2530/jslsm.jslsm-42_0003